Cargando…

Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder

AIM: To investigate the expression and clinical pathological significance of ROR2 and WNT5a in gallbladder squamous/adenosquamous carcinoma (SC/ASC) and adenocarcinoma (AC). METHODS: EnVision immunohistochemistry was used to stain for ROR2 and WNT5a in 46 SC/ASC patients and 80 AC patients. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zheng-Chun, Xiong, Li, Wang, Ling-Xiang, Miao, Xiong-Ying, Liu, Zi-Ru, Li, Dai-Qiang, Zou, Qiong, Liu, Kui-Jie, Zhao, Hua, Yang, Zhu-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Clinical Trials Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394524/ https://www.ncbi.nlm.nih.gov/pubmed/28465645 http://dx.doi.org/10.3748/wjg.v23.i14.2601

Ejemplares similares

Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma
por: Zou, Qiong, et al.
Publicado: (2013)

TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder
por: LIU, ZIRU, et al.
Publicado: (2014)

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder
por: Liu, Ziru, et al.
Publicado: (2016)

CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder
por: Dong, Fengyun, et al.
Publicado: (2015)

Metastatic gallbladder adenosquamous carcinoma to the skin(†)
por: Lupinacci, Renato Micelli, et al.
Publicado: (2014)

Adenosquamous Carcinoma of the Gallbladder With Sarcomatoid Features
por: Majeed, Nasma K., et al.
Publicado: (2020)

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
por: Parker, Barbara A., et al.
Publicado: (2023)

Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder
por: Jung, Jiyoon, et al.
Publicado: (2018)

Adenosquamous carcinoma of the gallbladder: a rare entity and dilemmas in its management
por: Zishan, Muhammed Ali, et al.
Publicado: (2023)

Gallbladder adenosquamous carcinoma: a case report and literature review
por: Davis, Tyler, et al.
Publicado: (2021)

Adenosquamous Carcinoma of Gallbladder with Unusual Prognosis: A Case Report
por: Gyawali, Siddinath, et al.
Publicado: (2023)

Adenosquamous Carcinoma of the Gallbladder: Case Report of a Rare Malignancy
por: Ishaya, Michelle M, et al.
Publicado: (2023)

Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis
por: Lv, Tian-Run, et al.
Publicado: (2023)

Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells
por: Wu, Xuping, et al.
Publicado: (2019)

A Case Report on Adenosquamous Carcinoma of Gallbladder: A Very Rare Malignancy
por: Mandal, Shobha, et al.
Publicado: (2021)

WNT5a-ROR Signaling Is Essential for Alveologenesis
por: Li, Changgong, et al.
Publicado: (2020)

Surgical resection of splenic metastasis from the adenosquamous gallbladder carcinoma: A case report
por: Utsumi, Masashi, et al.
Publicado: (2016)

Adenosquamous Carcinoma of the Gallbladder: A Clinicopathological, Immunohistochemical and Flow‐cytometric Study of Twenty Cases
por: Nishihara, Kazuyoshi, et al.
Publicado: (1994)

Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review
por: Huang, Junming, et al.
Publicado: (2021)

High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis
por: Zhang, Wei, et al.
Publicado: (2017)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Therapeutic response analysis for patients with adenosquamous carcinoma of the gallbladder: data analysis based on the Surveillance, Epidemiology, and End Results (SEER) database
por: Fang, Shenzhe, et al.
Publicado: (2023)

A Wnt-Frz/Ror-Dsh Pathway Regulates Neurite Outgrowth in Caenorhabditis elegans
por: Song, Song, et al.
Publicado: (2010)

Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy
por: Liu, Ping, et al.
Publicado: (2022)

Adenosquamous carcinoma of the lung
por: Li, Chenghui, et al.
Publicado: (2018)

Mixed adenocarcinoma, sarcomatoid carcinoma and adenosquamous carcinoma of the prostate: A case report
por: ZHANG, ZHONGFU, et al.
Publicado: (2014)

The role of WNT5A and Ror2 in peritoneal membrane injury
por: Padwal, Manreet, et al.
Publicado: (2020)

A Rare Case of Stage IV Mixed Neuroendocrine Small Cell and Adenosquamous Cell Carcinoma of the Gallbladder
por: Nuthulaganti, Swetha R, et al.
Publicado: (2022)

Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder
por: Zou, Qiong, et al.
Publicado: (2012)

Pulmonary micropapillary‐type adenosquamous carcinoma sharing epidermal growth factor receptor mutation in adenocarcinoma and squamous cell carcinoma
por: Takanashi, Yusuke, et al.
Publicado: (2016)

PSCA and Oct-4 Expression in the Benign and Malignant Lesions of Gallbladder: Implication for Carcinogenesis, Progression, and Prognosis of Gallbladder Adenocarcinoma
por: Zou, Qiong, et al.
Publicado: (2013)

ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a
por: Dai, Bin, et al.
Publicado: (2017)

Adenosquamous Versus Adenocarcinoma of the Pancreas: A Population-Based Outcomes Analysis
por: Katz, Matthew Harold G., et al.
Publicado: (2010)

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
por: Menck, Kerstin, et al.
Publicado: (2021)

The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma
por: Zhang, Zhiwei, et al.
Publicado: (2023)

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
por: Martin, Miguel, et al.
Publicado: (2016)

Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer
por: Xiong, Qunli, et al.
Publicado: (2022)

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)

A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
por: Chang, Chen, et al.
Publicado: (2022)

Adenosquamous carcinoma of the liver
por: Park, Shin Young, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l4300k9s66lafvhf6bc0lmsmfi